BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 11.95
+0.30 (2.58%)
Dec 15, 2025, 3:39 PM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 50.11 million as of December 15, 2025. Its market cap has decreased by -13.72% in one year.
Market Cap
50.11M
Enterprise Value
64.96M
Revenue
59.11M
Ranking
n/a
PE Ratio
79.67
Stock Price
11.95
Market Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 50.11M, an increase of 339.40%. That is a compound annual growth rate of 10.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 48.85M | 8.88% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | 119.23M | 792.90% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.66B |
| NEUCA | 3.66B |
| Synektik Spólka Akcyjna | 2.30B |
| Voxel | 1.27B |
| Celon Pharma | 1.08B |
| Selvita | 803.97M |
| Ryvu Therapeutics | 608.06M |
| Centrum Medyczne ENEL-MED | 514.70M |